Health & Biotech
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on Oventus Medical.
RELATED STOCKHEAD STORIES
Tech
Closing Bell: ASX plays catch up crash, wins
Health & Biotech
Check Up: Is biotech a good investment in a higher rate cycle? Turns out theory is just a theory
Health & Biotech
Check Up: Paradigm targets Phase 3 clinical trial in the US; AI microbiology product fails to impress
Experts
ScoPo’s Powerplays: Budget boost and inflation fears meet head on
News
Rise and Shine: What you need to know before the ASX opens
News
With America vaccinating 2 million a day, here are 3 ASX medtechs that will benefit as lockdowns are lifted
News
Trading Places: Fund managers are scrambling to buy education stocks
Health & Biotech
Oventus reckons its sleep apnoea device is less risky for COVID-19 transmission than CPAP
News
Lunchtime ASX small cap wrap: Who’s searching for a silver lining today?
News
10 at 10: These ASX stocks are on top of the hill this morning
Health & Biotech
Health: Oventus isn’t sleeping on the job because it’s making too much money
Health & Biotech
Dr Boreham’s Crucible: ResMed turbo-charges its sleep apnoea devices, races into new markets
Health & Biotech
Health: Oncosil stays hopeful with regulators, shares move higher
Health & Biotech
The Health Kick Podcast with Tim Boreham: Oventus Medical
Health & Biotech
Health: Poor pigs and dairy performance offsets feedlot wins at Apiam
Health & Biotech
Health: Pharmaxis tumbles way into the red as fortunes fluctuate on handballed drug
Health & Biotech